• 2026.06.19 (Fri)
  • All articles
  • LOGIN
  • JOIN
Global Economic Times
fashionrunwayshow2026
  • Synthesis
  • World
  • Business
  • Industry
  • ICT
  • Distribution Economy
  • Well+Being
  • Travel
  • Eco-News
  • Education
  • Korean Wave News
  • Opinion
  • Arts&Culture
  • Sports
  • People & Life
    • International Student Report
    • With Ambassador
  • Column
    • Cho Kijo Column
    • Cherry Garden Story
    • Ko Yong-chul Column
    • Kim Seul-Ong Column
    • Lee Yeon-sil Column
  • Photo News
  • New Book Guide
MENU
 
Home > Well+Being

Weight-Loss Drugs Like Wegovy Show Promise in Treating Male Infertility

Graciela Maria Reporter / Updated : 2026-06-18 09:43:15
  • -
  • +
  • Print


A groundbreaking study has revealed that popular weight-loss medications, including Wegovy and Saxenda, may offer significant benefits beyond shedding pounds—specifically, by boosting male reproductive health.

According to researchers at the University of Warwick and University Hospitals Coventry and Warwickshire, GLP-1 receptor agonists, a class of drugs widely used for obesity, have demonstrated a remarkable ability to improve sperm quality and restore hormonal balance in obese men.

Obesity has long been identified as a major contributor to male infertility, as excess body fat interferes with the natural hormonal systems required for healthy sperm production. This disruption often leads to structural abnormalities and decreased motility in sperm, significantly reducing the chances of conception. With one in 14 men worldwide experiencing infertility, these findings offer new hope.

The study analyzed data showing that patients treated with semaglutide—the active ingredient in Wegovy—for 24 weeks experienced not only weight reduction but also improved sperm structure. Furthermore, liraglutide, the core component of Saxenda, was found to return depleted testosterone levels to the normal range within just four months. Notably, patients using these weight-loss drugs exhibited better overall health outcomes compared to those undergoing traditional testosterone replacement therapy (TRT).

Dr. Pratibha Natesh, lead author of the study, warned against the growing trend of abusing TRT for muscle enhancement or perceived sexual health benefits. "Indiscriminate use of hormone injections can actually suppress the body’s natural hormonal regulation, potentially leading to testicular dysfunction or even permanent reproductive loss," Natesh cautioned.

"Instead of rushing into hormone therapy, men should prioritize resolving the root causes, such as obesity and metabolic dysfunction," she added. "Successfully managing one's weight allows the body to restore its own hormonal balance, which is vital for maintaining long-term reproductive function."

The research suggests that for many men, a prescription for weight loss might be the most effective—and safest—first step toward restoring both metabolic and reproductive vitality.

[Copyright (c) Global Economic Times. All Rights Reserved.]

  • #Hormuz Impasse
  • #globaleconomictimes
  • #micorea
  • #mykorea
  • #nammidonganews
  • #singaporenewsk
  • #Samsung
  • #Daewoo
  • #Hyos
Graciela Maria Reporter
Graciela Maria Reporter

Popular articles

  • White House Shooter Identified as 21-Year-Old Nasir Best with History of Mental Illness Claiming to be "Jesus"

  • Murata Unveils Next-Gen Resin Electrode MLCC for Automotive Applications

  • AI Laptops to Cross 50% Market Share Next Year as PC Giants Launch Full-Scale Offensive

I like it
Share
  • Facebook
  • X
  • Kakaotalk
  • LINE
  • BAND
  • NAVER
  • https://www.globaleconomictimes.kr/article/1065573727920544 Copy URL copied.
Comments >

Comments 0

Weekly Hot Issue

  • Fed Maintains Rates, But Shifts to Hawkish Stance Under Chair Warsh
  • The Changing Landscape of K-Beauty Jobs: Big Names Shrink as ODM and Beauty-Tech Firms Lead Growth
  • Trump Signs MOU to End Hostilities with Iran; Hormuz Strait "Free Access" Clause Sparks Controversy
  • AI Semiconductor Packaging Shifts Focus to 'Larger Footprints' and 'Advanced Thermal Management'
  • Asking about the Future of ‘Hangeul City Ulsan’… Special Lecture by Novelist Kim Jin-myung to be Held
  • Retail Investors Face Strict Penalties for 'Flipping' SpaceX IPO Shares

Most Viewed

1
Opening a 'New Horizon' for Korea-Pakistan Economic Cooperation… Exchange Event Successfully Held in Changwon
2
[In-depth Report] The Islamic ‘Halal Barrier’ Just Around the Corner… The Silent Screams of K-Beauty SMEs
3
[Interview] From Radiant Actor to Warm Companion… Actor Han Ji-il’s Great Second Act of Life
4
SK Telecom Ramps Up AI Drive with New Investment in Anthropic
5
Tesla and BYD Penetrate South Korea’s Stronghold as Domestic Auto Sales Stumble
광고문의
임시1
임시3
임시2

Hot Issue

Fed Maintains Rates, But Shifts to Hawkish Stance Under Chair Warsh

S. Korean Auto Industry Faces 'Triple Decline' in May, Despite Robust Growth in Eco-friendly Vehicles

Tragedy in LA: Police Shoot and Kill Pet Dog Mistaking Celebration for Distress Call

Weight-Loss Drugs Like Wegovy Show Promise in Treating Male Infertility

Fashion Runway Show 2026

Global Economic Times
korocamia@naver.com
CEO : LEE YEON-SIL
Publisher : KO YONG-CHUL
Registration number : Seoul, A55681
Registration Date : 2024-10-24
Youth Protection Manager: KO YONG-CHUL
Singapore Headquarters
5A Woodlands Road #11-34 The Tennery. S'677728
Korean Branch
Phone : +82(0)10 4724 5264
#304, 6 Nonhyeon-ro 111-gil, Gangnam-gu, Seoul
Copyright © Global Economic Times All Rights Reserved
  • 향기네무료급식
  • BCB부천방송
  • 반달곰 프로젝트
Search
Category
  • All articles
  • Synthesis
  • World
  • Business
  • Industry
  • ICT
  • Distribution Economy
  • Well+Being
  • Travel
  • Eco-News
  • Education
  • Korean Wave News
  • Opinion
  • Arts&Culture
  • Sports
  • People & Life 
    • 전체
    • International Student Report
    • With Ambassador
  • Column 
    • 전체
    • Cho Kijo Column
    • Cherry Garden Story
    • Ko Yong-chul Column
    • Kim Seul-Ong Column
    • Lee Yeon-sil Column
  • Photo News
  • New Book Guide
  • Multicultural News
  • Jobs & Workers